<aside>

Liquid embolics are embolization agents used in interventional radiology that exist in a liquid form at the time of injection and solidify within the vasculature to produce vessel occlusion.

</aside>

Unlike particulate embolics (which cause occlusion by mechanical obstruction), liquid embolics penetrate deeply into the vascular bed, providing more distal and durable occlusion.

![Liquid embolic agents and their usage scenarios and advantages.

Jiang Y, Zhang Y, Lu Z, et al. Liquid embolic agents for interventional embolization. ChemPhysMater. 2021;1(1):39-50. doi:10.1016/j.chphma.2021.09.008](attachment:b2bb4757-c57f-4272-9759-7c3b622322ff:1-s2.0-S2772571521000097-sc1_lrg.jpg)

Liquid embolic agents and their usage scenarios and advantages.

Jiang Y, Zhang Y, Lu Z, et al. Liquid embolic agents for interventional embolization. ChemPhysMater. 2021;1(1):39-50. doi:10.1016/j.chphma.2021.09.008

Classification


Class Agent Properties Utility
Adhesive Agents n-Butyl cyanoacrylate (n-BCA) (glue) Polymerize within seconds → immediate occlusion Fast, permanent, but operator-dependent.
Non-Adhesive Agents Onyx, Squid Precipitate gradually, allowing more controlled deposition and penetration Slower, safer, more controlled, especially in neurovascular use
Alcohol-Based Agents Absolute ethanol Direct cytotoxic injury to endothelium and vessel wall → thrombosis + fibrosis Destructive, highly effective in AVMs but with high complication risk

Indications


Neurointerventions • AVMs, AVFs, aneurysm adjunct therapy (Onyx, n-BCA).
Peripheral interventions • Gastrointestinal hemorrhage, bronchial artery embolization.
• Tumor devascularization (HCC, renal cell carcinoma).
Vascular malformations • Ethanol therapy for venous and AV malformations.

Imaging Perspective


Complications